Literature DB >> 9659276

Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.

L Ranganath1, H Jamal, L Jones, P F Goddard.   

Abstract

A previously well 70 year old woman was admitted to hospital following a three day history of vomiting and confusion. Her serum calcium was 6.58 mmol/l, phosphate 1.09 mmol/l, and alkaline phosphatase 91 iu/l. The mechanism of this hypercalcaemia was not obvious as there was no evidence of a primary malignancy, lymphadenopathy or hepatosplenomegaly. The calculation of indices of urinary excretion of calcium and phosphate suggested the presence of excessive parathyroid hormone (PTH) activity as the mechanism of hypercalcaemia. Plasma intact PTH, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol were not raised suggesting the presence of PTH related peptide (rP). This led to a systematic search for a malignancy, which revealed the presence of a high grade B cell non-Hodgkin's lymphoma confined to the bone marrow. Plasma PTH-rP was subsequently shown to be raised confirming the interpretation of the initial urinary and calcium excretion indices. This case highlights the value of standard laboratory measurements such as urinary calcium and phosphate excretion in cases of hypercalcaemia of obscure aetiology, which can complement measurements of PTH and other calcitropic hormones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659276      PMCID: PMC500655          DOI: 10.1136/jcp.51.3.257

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

Review 1.  Laboratory diagnosis of primary hyperparathyroidism.

Authors:  R Marcus
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

2.  Parathyroid hormone related protein (PTHrP) in hypercalcaemia of lymphoproliferative disease.

Authors:  S V Davies; J Vora; C A Wardrop
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

3.  Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy.

Authors:  F Firkin; J F Seymour; A M Watson; V Grill; T J Martin
Journal:  Br J Haematol       Date:  1996-09       Impact factor: 6.998

4.  Hypercalcaemia in hospital patients. Clinical and diagnostic aspects.

Authors:  R A Fisken; D A Heath; S Somers; A M Bold
Journal:  Lancet       Date:  1981-01-24       Impact factor: 79.321

5.  Parathyroid-hormone-related peptide in hematologic malignancies.

Authors:  R Kremer; C Shustik; T Tabak; V Papavasiliou; D Goltzman
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

  5 in total
  1 in total

1.  Hypercalcemia and huge splenomegaly presenting in an elderly patient with B-cell non-Hodgkin's lymphoma: a case report.

Authors:  Ali Am Ghazi; Hamid Attarian; Shirin Attarian; Abolghasem Abasahl; Ebrahim Daryani; Ebrahim Farasat; Marina Pourafkari; Farrokh Tirgari; Siavash M Ghazi; Kalman Kovacs
Journal:  J Med Case Rep       Date:  2010-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.